Skip to main content

Table 2 Pleural fluid and diagnostic studies

From: Efficacy of nonsurgical tigecycline pleurodesis for the management of hepatic hydrothorax in patients with liver cirrhosis

Findings

Case 1

Case 2

Pleural fluid

  WBC, 103/mm3

150

100

  Pleural/serum protein (ratio)

<0.5

<0.5

  SPAG

>1

>1

  Pleural LDH, IU/l

NA

49

  Culture

Negative

Negative

  Cytology

Negative

Negative

Tigecycline doses, total (mg)

150

200

Pleural drainage

  Before the PL, ml

2050

3500

  Following PL, ml

600

500

  Duration of drainage, days

10

14

Abdominal ultrasonography

Right massive pleural effusion with atelectasis left kidney stone (6 mm); liver: contour nodular, coarsened echo texture, C/RL >7, SM; ascites

Bilateral pleural effusion (right > left); liver: irregular external contour SM; minimal ascites

Doppler ultrasound following pleurodesis

Liver: contour nodular, coarsened echo texture SM, collaterals in the perisplenic region, portal venous thrombosis

Liver, coarsened echo texture, SM, patent vascular structure

Echocardiography

EF 55 %, 1° TR, 1° MR, left ventricular hypertrophy

EF 65 %, 1° TR, left atrial dilatation, aortic valve, and mitral annular calcification

  1. Abbreviations: LDH lactate dehydrogenase, SPAG serum–pleural fluid albumin gradient, EF ejection fraction, TR tricuspid regurgitation, MR mitral regurgitation, C/RL caudate–right lobe ratio, PL pleurodesis, NA not available